Ligand validation:5YHE

8UX: (2~{S})-4-[[(2~{R})-3-(1~{H}-imidazol-4-yl)-1-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-2-[[(2~{S})-1-oxidanyl-1-oxidanylidene-propan-2-yl]amino]butanoic acid

8UX is a Ligand Of Interest in 5YHE designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5YHE_8UX_A_604	81%	33%	0.129	0.981	0.99	1.64	-	4	0	0	100%	1
5YHE_8UX_B_602	78%	33%	0.133	0.976	0.94	1.7	1	4	0	0	100%	1
5YH8_8UX_A_602	94%	36%	0.08	0.979	1.13	1.37	1	3	0	0	100%	1
5YHG_8UX_A_608	78%	29%	0.135	0.979	1.28	1.57	2	4	0	0	100%	1
6H3F_8UX_A_601	4%	16%	0.3	0.665	1.59	2.09	4	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.